| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |